Toxic fibrillar oligomers of amyloid-β have cross-β structure

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 20, 2012, Pages 7717-7722

  Stroud, James C ^a   Liu, Cong ^a   Teng, Poh K ^a   Eisenberg, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Abeta oligomers; Alzheimer's disease; Domain swapping; Protein aggregation; Toxic oligomers

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; HEXAFLUORO 2 PROPANOL; OLIGOMER; TOXIC AMYLOID BETA PROTEIN[1-42] FIBRILLAR OLIGOMER; UNCLASSIFIED DRUG;

ARTICLE; CELL SURVIVAL; CIRCULAR DICHROISM; CYTOTOXICITY; DEGENERATIVE DISEASE; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; GEL PERMEATION CHROMATOGRAPHY; NERVE CELL; PRIORITY JOURNAL; PROTEIN STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

AMYLOID BETA-PEPTIDES; CIRCULAR DICHROISM; MICROSCOPY, ELECTRON; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84861206757     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1203193109     Document Type: Article

References (52)

1. Selkoe DJ (2003) Folding proteins in fatal ways. Nature 426:900-904.
2. Kirkitadze MD, Bitan G, Teplow DB (2002) Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies. J Neurosci Res 69:567-577. (Pubitemid 34966869)
3. Bucciantini M, et al. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:507-511. (Pubitemid 34288846)
4. Ewbank DC (1999) Deaths attributable to Alzheimer's disease in the United States. Am J Public Health 89:90-92.
5. Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM (2008) Protein aggregation in the brain: The molecular basis for Alzheimer's and Parkinson's diseases. Mol Med 14:451-464.
6. Li S, et al. (2009) Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62:788-801.
7. Calabrese B, et al. (2007) Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-beta protein. Mol Cell Neurosci 35:183-193. (Pubitemid 46843559)
8. Martins IC, et al. (2008) Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J 27:224-233.
9. Barghorn S, et al. (2005) Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem 95:834-847. (Pubitemid 41567174)
10. Westermark P, et al. (2007) A primer of amyloid nomenclature. Amyloid 14:179-183. (Pubitemid 47262691)
11. Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267-298. (Pubitemid 37064935)
12. Glabe CG (2008) Structural classification of toxic amyloid oligomers. J Biol Chem 283:29639-29643.
13. Kayed R, et al. (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener 2:18.
14. Wu JW, et al. (2010) Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation. J Biol Chem 285:6071-6079.
15. Bonar L, Cohen AS, Skinner MM (1969) Characterization of the amyloid fibril as a cross-beta protein. Proc Soc Exp Biol Med 131:1373-1375.
16. Eanes ED, Glenner GG (1968) X-ray diffraction studies on amyloid filaments. J Histochem Cytochem 16:673-677.
17. Astbury WT, Dickinson S, Bailey K (1935) The X-ray interpretation of denaturation and the structure of the seed globulins. Biochem J 29:2351-2360.
18. Jahn TR, et al. (2010) The common architecture of cross-beta amyloid. J Mol Biol 395:717-727.
19. Kirschner DA, Abraham C, Selkoe DJ (1986) X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. Proc Natl Acad Sci USA 83:503-507. (Pubitemid 16080042)
20. Sunde M, et al. (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol 273:729-739. (Pubitemid 27488813)
21. Colletier J-P, et al. (2011) Molecular basis for amyloid-beta polymorphism. Proc Natl Acad Sci USA 108:16938-16943.
22. Lührs T, et al. (2005) 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc Natl Acad Sci USA 102:17342-17347.
23. Petkova AT, et al. (2002) A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99:16742-16747. (Pubitemid 36034043)
24. Finder VH, Vodopivec I, Nitsch RM, Glockshuber R (2010) The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42. J Mol Biol 396:9-18.
25. Mok Y-F, Howlett GJ (2006) Sedimentation velocity analysis of amyloid oligomers and fibrils. Methods Enzymol 413:199-217.
26. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
27. Perez-Iratxeta C, Andrade-Navarro MA (2008) K2D2: Estimation of protein secondary structure from circular dichroism spectra. BMC Struct Biol 8:25.
28. Johnson WC (1999) Analyzing protein circular dichroism spectra for accurate secondary structures. Proteins 35:307-312.
29. Kelly SM, Price NC (2000) The use of circular dichroism in the investigation of protein structure and function. Curr Protein Pept Sci 1:349-384.
30. Kong J, Yu S (2007) Fourier transform infrared spectroscopic analysis of protein secondary structures. Acta Biochim Biophys Sin (Shanghai) 39:549-559. (Pubitemid 47293710)
31. Susi H, Byler DM (1988) Fourier deconvolution of the amide I Raman band of proteins as related to conformation. Appl Spectrosc 42:819-826. (Pubitemid 18649875)
32. Chirgadze YN, Nevskaya NA (1976) Infrared spectra and resonance interaction of amide-I vibration of the antiparallel-chain pleated sheet. Biopolymers 15:607-625.
33. Harris KDM, Johnston RL, Kariuki BM (1998) The genetic algorithm: Foundations and applications in structure solution from powder diffraction data. Acta Crystallogr A 54:632-645. (Pubitemid 128501848)
34. Hoyer W, Grönwall C, Jonsson A, Ståhl S, Härd T (2008) Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation. Proc Natl Acad Sci USA 105:5099-5104. (Pubitemid 351738516)
35. Sandberg A, et al. (2010) Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering. Proc Natl Acad Sci USA 107:15595-15600.
36. Tycko R, Sciarretta KL, Orgel JPRO, Meredith SC (2009) Evidence for novel beta-sheet structures in Iowa mutant beta-amyloid fibrils. Biochemistry 48:6072-6084.
37. Guo Z, Eisenberg D (2006) Runaway domain swapping in amyloid-like fibrils of T7 endonuclease I. Proc Natl Acad Sci USA 103:8042-8047. (Pubitemid 43801049)
38. 2-microglobulin forms three-dimensional domain-swapped amyloid fibrils with disulfide linkages. Nat Struct Mol Biol 18:49-55.
39. Sambashivan S, Liu Y, Sawaya MR, Gingery M, Eisenberg D (2005) Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure. Nature 437:266-269. (Pubitemid 41294490)
40. Evans PR, Farrants GW, Hudson PJ (1981) Phosphofructokinase: Structure and control. Philos Trans R Soc Lond B Biol Sci 293:53-62.
41. Jiménez JL, et al. (2002) The protofilament structure of insulin amyloid fibrils. Proc Natl Acad Sci USA 99:9196-9201. (Pubitemid 34764590)
42. Wang J, Gülich S, Bradford C, Ramirez-Alvarado M, Regan L (2005) A twisted four-sheeted model for an amyloid fibril. Structure 13:1279-1288. (Pubitemid 41262095)
43. Nelson R, et al. (2005) Structure of the cross-beta spine of amyloid-like fibrils. Nature 435:773-778. (Pubitemid 40839722)
44. Liu C, et al. (2011) Characteristics of amyloid-related oligomers revealed by crystal structures of macrocyclic β-sheet mimics. J Am Chem Soc 133:6736-6744.
45. Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT, Jr. (2002) Neurodegenerative disease: Amyloid pores from pathogenic mutations. Nature 418:291. (Pubitemid 34790672)
46. Zhu YJ, Lin H, Lal R (2000) Fresh and nonfibrillar amyloid beta protein(1-40) induces rapid cellular degeneration in aged human fibroblasts: Evidence for AbetaP-channel-mediated cellular toxicity. FASEB J 14:1244-1254. (Pubitemid 30350406)
47. Stine WB, Jr., Dahlgren KN, Krafft GA, LaDu MJ (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278:11612-11622. (Pubitemid 36792723)
48. Sheldrick GM (2008) A short history of SHELX. Acta Crystallogr A 64:112-122.
49. Collaborative Computational Project, Number 4 (1994) The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50:760-763.
50. Yamashita E, Zhalnina MV, Zakharov SD, Sharma O, Cramer WA (2008) Crystal structures of the OmpF porin: Function in a colicin translocon. EMBO J 27:2171-2180.
51. Mastrangelo IA, et al. (2006) High-resolution atomic force microscopy of soluble Abeta42 oligomers. J Mol Biol 358:106-119.
52. Leinala EK, et al. (2002) A beta-helical antifreeze protein isoform with increased activity. Structural and functional insights. J Biol Chem 277:33349-33352. (Pubitemid 34984858)